Biophage Inc., Immune Network Research Ltd. deal

The companies will develop IMM's 1F7 antibody to treat AIDS and an undisclosed Biophage antibody. The companies plan to fund and own the compounds jointly. IMM plans to start a Phase I/II trial of 1F7 in the second half of the year. ...